loadpatents
name:-0.050832986831665
name:-0.028201103210449
name:-0.007112979888916
DABDOUBI; Tarik Patent Filings

DABDOUBI; Tarik

Patent Applications and Registrations

Patent applications and USPTO patent grants for DABDOUBI; Tarik.The latest application filed is for "anti-cd38 antibodies and methods of use".

Company Profile
5.13.21
  • DABDOUBI; Tarik - Paris FR
  • DABDOUBI; Tarik - Le Coudray Montceaux FR
  • Dabdoubi; Tarik - La Coudray Montceaux FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-cd38 Antibodies And Methods Of Use
App 20220275102 - CAMERON; Beatrice ;   et al.
2022-09-01
Anti-CD38 antibodies and methods of use
Grant 11,365,261 - Cameron , et al. June 21, 2
2022-06-21
Anti-CEACAM5 antibodies and uses thereof
Grant 11,332,542 - Berne , et al. May 17, 2
2022-05-17
Anti-cd38 Antibodies And Methods Of Use
App 20220041746 - CAMERON; Beatrice ;   et al.
2022-02-10
Anti-CD38 antibodies and methods of use
Grant 11,186,649 - Wu , et al. November 30, 2
2021-11-30
Trispecific Binding Proteins, Methods, And Uses Thereof
App 20200399369 - ASOKAN; Mangaiarkarasi ;   et al.
2020-12-24
Trispecific Anti-cd38, Anti-cd28, And Anti-cd3 Binding Proteins And Methods Of Use For Treating Viral Infection
App 20200140552 - WU; Lan ;   et al.
2020-05-07
Anti-ceacam5 Antibodies And Uses Thereof
App 20200102401 - BERNE; Pierre-Francois ;   et al.
2020-04-02
Anti-CEACAM5 antibodies and uses thereof
Grant 10,457,739 - Berne , et al. Oc
2019-10-29
Anti-cd38 Antibodies And Methods Of Use
App 20190106504 - WU; Lan ;   et al.
2019-04-11
Anti-lamp1 Antibodies And Antibody Drug Conjugates, And Uses Thereof
App 20180142032 - BAUDAT; Yves ;   et al.
2018-05-24
Anti-ceacam5 Antibodies And Uses Thereof
App 20180022817 - BERNE; Pierre-Francois ;   et al.
2018-01-25
Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof
Grant 9,809,653 - Baudat , et al. November 7, 2
2017-11-07
Anti-CEACAM5 antibodies and uses thereof
Grant 9,617,345 - Berne , et al. April 11, 2
2017-04-11
Robo1-Fc fusion protein and use thereof for treating tumours
Grant 9,493,529 - Blanche , et al. November 15, 2
2016-11-15
Anti-lamp1 Antibodies And Antibody Drug Conjugates, And Uses Thereof
App 20160280793 - BAUDAT; Yves ;   et al.
2016-09-29
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 9,441,040 - Baurin , et al. September 13, 2
2016-09-13
Peptide Or Peptide Complex Binding To Alpha2 Integrin And Methods And Uses Involving The Same
App 20160176970 - Corvey; Carsten ;   et al.
2016-06-23
Anti-ceacam5 Antibodies And Uses Thereof
App 20160108131 - BERNE; Pierre-Francois ;   et al.
2016-04-21
Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same
Grant 9,234,039 - Corvey , et al. January 12, 2
2016-01-12
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20150098939 - BAURIN; Nicolas ;   et al.
2015-04-09
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 8,852,593 - Baurin , et al. October 7, 2
2014-10-07
Peptide Or Peptide Complex Binding To 2 Integrin And Methods And Uses Involving The Same
App 20130156786 - Corvey; Carsten ;   et al.
2013-06-20
Anti-gitr Antibodies
App 20130108641 - Baurin; Nicolas ;   et al.
2013-05-02
Robo1-fc Fusion Protein And Use Thereof For Treating Tumours
App 20130039912 - Blanche; Francis ;   et al.
2013-02-14
Polypeptides For Binding To The Receptor For Advanced Glycation Endproducts As Well As Compositions And Methods Involving
App 20120282637 - Huber; Jochen ;   et al.
2012-11-08
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20120244152 - Baurin; Nicolas ;   et al.
2012-09-27
Fgf-r4 Receptor-specific Antagonists
App 20110150903 - Baurin; Nicolas ;   et al.
2011-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed